The order will simplify medical research
Donald Trump, the President of the United States, has signed a new order aimed at accelerating the process of reclassifying marijuana. However, experts emphasize that this should not be perceived as the legalization of cannabis, reports Tengrinews.kz, citing CNN.
According to information from senior officials in the Trump administration, this order mandates Attorney General Pam Bondi to expedite the process of easing federal restrictions, although specific timelines are not provided. This step is a result of active lobbying by the cannabis industry.
“The signed order will significantly simplify the conduct of medical research related to marijuana, allowing us to study its benefits, potential risks, and new treatment methods. This will have an extremely positive impact,” Trump noted in the Oval Office.
Currently, marijuana in the U.S. is classified as a Schedule I drug, alongside substances like heroin and LSD, which, according to the Drug Enforcement Administration (DEA), have no recognized medical use.
Under the new order, marijuana could be reclassified as a Schedule III drug, which, as the DEA indicates, has “a moderate or low potential for physical and psychological dependence.”
“The facts compel the federal government to recognize that marijuana can be a legal medical option when used responsibly. In some cases, it may serve as an alternative to opioid painkillers, which are addictive and can be dangerous,” Trump added, calling the decision “common sense.”
However, it is worth noting that Trump’s actions do not legalize marijuana at the federal level, even though it is already legal in several states. The order does not address issues of recreational marijuana use and does not make changes to the criminal justice system.
The U.S. Department of Health and Human Services has also been tasked with conducting research aimed at expanding access to CBD products derived from hemp.
Photo www
